Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report

Endometrial cancer arising in adenomyosis (EC-AIA) is a rare form of uterine cancer. A 53-year-old Japanese postmenopausal female was referred to our outpatient clinic for adenomyosis. After the 4-year follow-up, she presented with an increased vaginal discharge. Endometrial curettage demonstrated e...

Full description

Bibliographic Details
Main Authors: Hiroaki NAGANO, Yuri FURUKAWA, Mariko UENO, Koichiro TAKAGI
Format: Article
Language:English
Published: Society of Tokyo Women's Medical University 2018-10-01
Series:Tokyo Women's Medical University Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/twmuj/2/0/2_2018004/_pdf/-char/en
_version_ 1818408465061642240
author Hiroaki NAGANO
Yuri FURUKAWA
Mariko UENO
Koichiro TAKAGI
author_facet Hiroaki NAGANO
Yuri FURUKAWA
Mariko UENO
Koichiro TAKAGI
author_sort Hiroaki NAGANO
collection DOAJ
description Endometrial cancer arising in adenomyosis (EC-AIA) is a rare form of uterine cancer. A 53-year-old Japanese postmenopausal female was referred to our outpatient clinic for adenomyosis. After the 4-year follow-up, she presented with an increased vaginal discharge. Endometrial curettage demonstrated either atypical endometrial hyperplasia or well-differentiated endometrioid carcinoma. Positron emission tomography/computed tomography revealed multiple pulmonary metastases, pelvic bone metastases, para-aortic node metastases, and uterine tumor as the primary lesion. She was clinically diagnosed with stage IVB endometrial cancer. Accordingly, total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. Macroscopic findings of the resected uterus were difficult to distinguish from ordinal adenomyosis. Microscopically, diffuse endometrioid carcinoma (grade 2) occupied the entire uterine body, coexisting with adenomyosis. Postoperatively, chemotherapy and zoledronic acid administration were initiated, which are ongoing till date. The case highlights that EC-AIA, a rare but aggressive disease, should be considered when managing patients with adenomyosis.
first_indexed 2024-12-14T09:44:09Z
format Article
id doaj.art-e5b99814a3f94c1ea6224654339e83c6
institution Directory Open Access Journal
issn 2432-6186
language English
last_indexed 2024-12-14T09:44:09Z
publishDate 2018-10-01
publisher Society of Tokyo Women's Medical University
record_format Article
series Tokyo Women's Medical University Journal
spelling doaj.art-e5b99814a3f94c1ea6224654339e83c62022-12-21T23:07:43ZengSociety of Tokyo Women's Medical UniversityTokyo Women's Medical University Journal2432-61862018-10-0120404410.24488/twmuj.2018004twmujAdvanced Endometrial Cancer Arising in Adenomyosis: A Case ReportHiroaki NAGANO0Yuri FURUKAWA1Mariko UENO2Koichiro TAKAGI3Department of Obstetrics and Gynecology, Tokyo Women's Medical University Medical Center EastDepartment of Obstetrics and Gynecology, Tokyo Women's Medical University Medical Center EastDepartment of Obstetrics and Gynecology, Tokyo Women's Medical University Medical Center EastDepartment of Obstetrics and Gynecology, Tokyo Women's Medical University Medical Center EastEndometrial cancer arising in adenomyosis (EC-AIA) is a rare form of uterine cancer. A 53-year-old Japanese postmenopausal female was referred to our outpatient clinic for adenomyosis. After the 4-year follow-up, she presented with an increased vaginal discharge. Endometrial curettage demonstrated either atypical endometrial hyperplasia or well-differentiated endometrioid carcinoma. Positron emission tomography/computed tomography revealed multiple pulmonary metastases, pelvic bone metastases, para-aortic node metastases, and uterine tumor as the primary lesion. She was clinically diagnosed with stage IVB endometrial cancer. Accordingly, total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. Macroscopic findings of the resected uterus were difficult to distinguish from ordinal adenomyosis. Microscopically, diffuse endometrioid carcinoma (grade 2) occupied the entire uterine body, coexisting with adenomyosis. Postoperatively, chemotherapy and zoledronic acid administration were initiated, which are ongoing till date. The case highlights that EC-AIA, a rare but aggressive disease, should be considered when managing patients with adenomyosis.https://www.jstage.jst.go.jp/article/twmuj/2/0/2_2018004/_pdf/-char/enendometrial carcinomaadenomyosismalignant transformation
spellingShingle Hiroaki NAGANO
Yuri FURUKAWA
Mariko UENO
Koichiro TAKAGI
Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report
Tokyo Women's Medical University Journal
endometrial carcinoma
adenomyosis
malignant transformation
title Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report
title_full Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report
title_fullStr Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report
title_full_unstemmed Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report
title_short Advanced Endometrial Cancer Arising in Adenomyosis: A Case Report
title_sort advanced endometrial cancer arising in adenomyosis a case report
topic endometrial carcinoma
adenomyosis
malignant transformation
url https://www.jstage.jst.go.jp/article/twmuj/2/0/2_2018004/_pdf/-char/en
work_keys_str_mv AT hiroakinagano advancedendometrialcancerarisinginadenomyosisacasereport
AT yurifurukawa advancedendometrialcancerarisinginadenomyosisacasereport
AT marikoueno advancedendometrialcancerarisinginadenomyosisacasereport
AT koichirotakagi advancedendometrialcancerarisinginadenomyosisacasereport